Join to View Full Profile
300 3rd StreetCambridge, MA 02142
Phone+1 617-732-5500
Dr. Garg is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of California (San Francisco)Residency, Internal Medicine, 1993 - 1996- University of California San Francisco School of MedicineClass of 1993
Publications & Presentations
PubMed
- 133 citationsVutrisiran in Patients with Transthyretin Amyloidosis with Cardiomyopathy.Marianna Fontana, John L Berk, Julian D Gillmore, Ronald M Witteles, Martha Grogan
The New England Journal of Medicine. 2025-01-02 - 124 citationsPatisiran Treatment in Patients with Transthyretin Cardiac Amyloidosis.Mathew S Maurer, Parag Kale, Marianna Fontana, John L Berk, Martha Grogan
The New England Journal of Medicine. 2023-10-26 - 11 citationsResults of a phase 1/2 study of cemdisiran in healthy subjects and patients with paroxysmal nocturnal hemoglobinuria.Anna Gaya, Talha Munir, Alvaro Urbano-Ispizua, Morag Griffin, Jorg Taubel
Ejhaem. 2023-08-01
Press Mentions
FDA Approves Acoramidis, BridgeBio’s New ATTR-CM DrugNovember 23rd, 2024- Alnylam Presents Positive Results from the APOLLO-B Phase 3 Study of Patisiran in Patients with ATTR Amyloidosis with CardiomyopathySeptember 8th, 2022
- Patisiran Meets Primary Endpoint in Trial for ATTR Amyloidosis, CardiomyopathyAugust 4th, 2022
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
